glp 1 agonist half life Another milestone in the evolution of GLP-1-based diabetes therapies Emesis after taking a long-acting
Description
Patent protection : GLP-1 medications are still under patent, which means there are no low-cost generic versions yet, and are only sold by the brand-name pharmaceutical company that manufactures them
C., Sheka A
Studies have shown that GLP-1 receptor agonists are effective for preventing or managing obesity
Several systematic reviews also indicated that GLP-1RAs are consistently effective at reducing body weight [25, 41, 42, 44], supporting the nonglycaemic role of this agent class [44], as opposed to the weight gain that commonly accompanies insulin treatment [44]
Laufer, P
